Hem Preparat/substans Diagnos/indikation Kontakt
A B C D E F G H I J K L M N O P Q R S T U V X Y Z Å Ä Ö

Referenser för Faslodex

 

Författare, artikel och publikation

År

 

Hämta abstract / fulltext

 

1. Howell A et al. Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment.
J Clin Oncol. 2002: 3396-403.

2002 

 

2. Osborne CK et al. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial.
J Clin Oncol, 2002:3386-95.

2002

3. Mauriac L et al. Fulvestrant (Faslodex) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials.
Eur J Cancer, 2003:1228-33.

2003